Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway. | Lab Invest | 2023 | 36990154 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| Identification of Cancer Driver Genes by Integrating Multiomics Data with Graph Neural Networks. | Metabolites | 2023 | 36984779 | PubTator, text mining | PubMed |
| METTL3-Mediated LncRNA EN_42575 m6A Modification Alleviates CPB2 Toxin-Induced Damage in IPEC-J2 Cells. | Int J Mol Sci | 2023 | 36982798 | PubTator, text mining | PubMed |
| Epigenetic Regulation Mediated by Sphingolipids in Cancer. | Int J Mol Sci | 2023 | 36982369 | PubTator, text mining | PubMed |
| FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis. | Genes (Basel) | 2023 | 36981005 | PubTator, text mining | PubMed |
| Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. | Ann Med | 2023 | 36974635 | PubTator, text mining | PubMed |
| Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation. | Nat Commun | 2023 | 36973285 | PubTator, text mining | PubMed |
| Rolling circle extension-assisted loop-mediated isothermal amplification (Rol-LAMP) method for locus-specific and visible detection of RNA N6-methyladenosine. | Nucleic Acids Res | 2023 | 36971119 | PubTator, text mining | PubMed |
| Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics. | Open Life Sci | 2023 | 36970605 | PubTator, text mining | PubMed |
| The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer. | Front Oncol | 2023 | 36969033 | PubTator, text mining | PubMed |
| Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II. | Front Oncol | 2023 | 36968996 | PubTator, text mining | PubMed |
| The m6A reader PRRC2A is essential for meiosis I completion during spermatogenesis. | Nat Commun | 2023 | 36964127 | PubTator, text mining | PubMed |
| METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. | Oncol Rep | 2023 | 36960869 | PubTator, text mining | PubMed |
| Roles and therapeutic implications of m6A modification in cancer immunotherapy. | Front Immunol | 2023 | 36960074 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition. | J Mol Cell Biol | 2023 | 36945110 | PubTator, text mining | PubMed |
| m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis. | Mol Cell | 2023 | 36944332 | Swiss-Prot, curated | PubMed |
| N6 - Methyladenosine defines a new checkpoint in γδ T cell development. | Bioessays | 2023 | 36942692 | PubTator, text mining | PubMed |
| The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response. | Cancer Res | 2023 | 36939388 | PubTator, text mining | PubMed |
| Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients. | Front Surg | 2023 | 36936652 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=60